CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma.

MLA

Pal, Sumanta K., et al. “CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma.” Cancer Discovery, vol. 14, no. 7, July 2024, pp. 1176–89. EBSCOhost, https://doi.org/10.1158/2159-8290.CD-24-0102.

APA

Pal, S. K., Tran, B., Haanen, J. B. A. G., Hurwitz, M. E., Sacher, A., Tannir, N. M., Budde, L. E., Harrison, S. J., Klobuch, S., Patel, S. S., Meza, L., Dequeant, M.-L., Ma, A., He, Q. A., Williams, L. M., Keegan, A., Gurary, E. B., Dar, H., Karnik, S., … Srour, S. A. (2024). CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma. Cancer Discovery, 14(7), 1176–1189. https://doi.org/10.1158/2159-8290.CD-24-0102

Chicago

Pal, Sumanta K, Ben Tran, John B A G Haanen, Michael E Hurwitz, Adrian Sacher, Nizar M Tannir, Lihua E Budde, et al. 2024. “CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma.” Cancer Discovery 14 (7): 1176–89. doi:10.1158/2159-8290.CD-24-0102.